Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 6, 2025 $903.47 +9.37% $870.37 V 96.20% 1
Jan 27, 2025 $776.09 -1.19% $808.17 X 96.03% 0
Jan 27, 2025 $779.58 -0.74% $808.17 X 96.46% 0
Jan 27, 2025 Bullish $808.17 V 1
Jan 24, 2025 $757.47 -1.19% $785.41 X 96.44% 0
Jan 24, 2025 $760.89 -0.74% $785.41 X 96.88% 0
Jan 24, 2025 $805.71 +5.10% $785.41 V 97.42% 1
Jan 23, 2025 Bearish $766.60 X 0
Jan 16, 2025 $755.85 +1.22% $757.60 V 99.77% 6
Jan 16, 2025 $752.43 +0.76% $757.60 V 99.32% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE